Skip to main content

Publications & Presentations

Publications & Presentations

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology

Current clinical risk stratification methods for localized prostate cancer are suboptimal, leading to over- and undertreatmen [...]

Read more

Publications & Presentations

Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specif [...]

Read more

Publications & Presentations

Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer

This is the first study of which we are aware to describe the analytical validation (AV) of clinical grade artificial intelli [...]

Read more

Publications & Presentations

Advancing Precision Oncology with Artificial Intelligence: Ushering in the ArteraAI Prostate Test

Due to the negative effects of excessive and inadequate treatment, prostate cancer (PCa) represents the most common cause of [...]

Read more

Publications & Presentations

External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial

Accurate risk stratification is critical to guide management decisions in localized prostate cancer (PCa). Previously, we had [...]

Read more

Publications & Presentations

Can AI-Driven Cancer Care Help Improve Mental Well-Being?

AI-enabled predictive and prognostic tests allow clinicians a line of sight.

Read more

Publications & Presentations

ArteraAI Validates its Prognostic Model in Advanced Prostate Cancer

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announces [...]

Read more

Publications & Presentations

AI biomarker predictive of long-term ADT benefit in patients with prostate cancer

Investigators have validated the first AI-derived predictive biomarker of long-term androgen deprivation therapy (ADT) benefi [...]

Read more

Publications & Presentations

The Vital Role of Clinical Validation in the Adoption of AI within Healthcare

The healthcare industry has witnessed a significant surge in interest and opportunity to integrate artificial intelligence (A [...]

Read more

1 2 3